Who's in the room.
The clinicians at MVMNT write protocol, set formulary, and decide which therapies, diagnostics, and technologies move from edge to standard of care. The health system leaders alongside them decide how those decisions get resourced across institutions. This is where the next three years of longevity practice get sketched.
Why they're there.
Longevity medicine is moving faster than the literature can keep up. The clinicians who come to MVMNT come because they need an evidence-graded filter from peers doing the work — what's clinically defensible now, what's promising, what's premature. They are not browsing. They are deciding what to bring back to practice.
What it means for you.
Proximity to clinical decision-making, at the moment it's happening, in a cohort small enough that proximity is real.